View Systems Expands Staff of Medical Therapeutics


BALTIMORE, MD, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Medical Therapeutics, a wholly owned subsidiary of View Systems, Inc. (OTC Pink: VSYM), today announced that it has hired additional professionals to staff  its new medical division, Medical Therapeutics, a concierge medical service providing sexual health therapies with FDA approved medicines. These markets are projected to reach $7.64 billion in 2019.

Martin Maassen, MD, Medical Director of Medical Therapeutics, states, "We have hired three additional staff members including: a seasoned professional from the industry, Mr. William Kelley as Managing Director.  Mr. Kelley has stellar credentials; he served as an Army Ranger, retired as a State Trooper in Pennsylvania and was trained in the industry by Dr. S. Dianzumba, Cardiologist and Dr. M. Trombly, Urologist.  Mr. Kelley also has been trained through the Board of Urology and has successfully managed multiple clinics."

We will also aggressively open additional clinics in 2018. The demographics of the industry indicate there are over 50 million men over the age of fifty who are experiencing age and health related hormonal difficulties.  A variety of maladies such as diabetes, high blood pressure, prostate difficulties, side effects of prescription drugs, testosterone decline and cardiovascular issues make intimacy even more difficult.

About View Systems/Medical Therapeutics:

View Systems, Inc. is entering new and additional markets to include boutique medical clinics offering a variety of specialized procedures to appropriate patient demographics.

Safe Harbor Statement:  This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.



            

Contact Data